Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
NCT ID: NCT00735124
Last Updated: 2017-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
5 participants
INTERVENTIONAL
2008-11-06
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Gabapentin on Post-Operative Pain in Minimally Invasive Sacrocolpopexy
NCT05609682
Effect of Perioperative Gabapentin on Postoperative Opioid Requirements
NCT05494385
Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion
NCT03151746
A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain After Inguinal Hernia Repair
NCT04700592
The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair
NCT02419443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single pre-op dose of Gabapentine
Active treatment with the study drug
Gabapentin
1200 mg single dose gabapentin
Placebo
Placebo arm for blinding the medication
placebo
Injection of placebo/sham
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gabapentin
1200 mg single dose gabapentin
placebo
Injection of placebo/sham
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients currently on gabapentin therapy
* Patient hypersensitive to gabapentin surgery
* History of alcohol or drug abuse
* Patients who are pregnant or who are nursing
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oklahoma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Badie Mansour, MD
Role: PRINCIPAL_INVESTIGATOR
OUHSC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OUHSC
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.